Cancer Cell-derived IL-8 Induces Monocytic THP1 Cells to Secrete IL-8 Via the Mitogen-activated Protein Kinase Pathway
Overview
Affiliations
Aberrant activity of transcription factors in oral squamous cell carcinoma (OSCC) results in the spontaneous secretion of various cytokines and chemokines. Among them, IL-8, owing to its angiogenic activity, promotes the growth of OSCCs. In the present study, we examined the role of IL-8 secreted by OSCCs, on the angiogenic activity of monocytic THP1 cells. Culture supernatant (Ca-sup) augmented IL-8 secretion by THP1 cells, which was found to be significantly reduced following the removal Ca9-22-derived IL-8 from the Ca-sup. IL-8 induction was regulated at the transcriptional level, because real-time PCR demonstrated the augmented IL-8 messenger RNA (mRNA) expression. We further performed the luciferase assay using the 5'-untranslated region of IL-8 gene. Contradictory to our speculations, luciferase activity was not augmented by Ca-sup stimulation. NF-κB-independent IL-8 induction was further confirmed by pre-treating THP1 cells with NF-κB-specific inhibitors. To elucidate the signaling pathway, THP1 was pre-treated with MEK inhibitors. The results demonstrated that pre-treatment of cells with MEK inhibitor drastically reduced IL-8 levels, suggesting the role of MEK. Moreover, Ca-sup was found to increase ERK1/2 phosphorylation in a time-dependent manner. These results indicated that OSCC-derived IL-8 appears to activate angiogenic activity in monocytes within the tumor microenvironment via the mitogen-activated protein kinase (MAPK) pathway.
New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis.
Chen S, Hsiao S, Chang K, Chang J Int J Mol Sci. 2021; 22(5).
PMID: 33668218 PMC: 7956378. DOI: 10.3390/ijms22052252.
Petruzzi M, Cherubini K, Salum F, de Figueiredo M Diagn Pathol. 2017; 12(1):32.
PMID: 28381274 PMC: 5382416. DOI: 10.1186/s13000-017-0623-6.
IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway.
Chan L, Wang L, Chiang F, Lee K, Kuo P, Liang C Oncotarget. 2016; 7(38):61820-61831.
PMID: 27557518 PMC: 5308693. DOI: 10.18632/oncotarget.11445.
Fu H, Ma Y, Yang M, Zhang C, Huang H, Xia Y Sci Rep. 2016; 6:29762.
PMID: 27412620 PMC: 4944193. DOI: 10.1038/srep29762.
Tafani M, Sansone L, Limana F, Arcangeli T, De Santis E, Polese M Oxid Med Cell Longev. 2016; 2016:3907147.
PMID: 26798421 PMC: 4699039. DOI: 10.1155/2016/3907147.